...
首页> 外文期刊>Talanta: The International Journal of Pure and Applied Analytical Chemistry >Paper-based colorimetric spot test utilizing smartphone sensing for detection of biomarkers
【24h】

Paper-based colorimetric spot test utilizing smartphone sensing for detection of biomarkers

机译:利用智能手机检测检测生物标志物的纸基比色点试验

获取原文
获取原文并翻译 | 示例
           

摘要

The need for a continuous, real-time monitoring of specific diseases represents an unmet scientific need. Evidently, cancer is one of the most important diseases where it is crucial to increase the rates of patient survival and monitor disease prognosis. Herein, a novel type of immunoassay was developed for detection of cancer biomarkers, using alpha-fetoprotein (AFP) and mucin-16 (MUC16) as model analytes. Using gold nanoparticle (AuNP) bioconjugates as a signal production tool, relevant antibody (Ab)-conjugated AuNPs were prepared on the nitrocellulose (NC) membrane. To construct a spot-like point-of-care (POC) immunoassay, cysteamine conjugated AuNPs (AuNP-Cys) were immobilized on the NC membrane and antibodies were conjugated to the nanoparticle on the detection pad, following a treatment with the samples that contains AFP or MUC16 which are well-known protein biomarkers for liver and ovarian cancer. By using the change in the colorimetric properties of AuNPs, detection of tumor markers was achieved by using a smartphone image and color analysis software at the final stage. Image J application was used for the evaluation of color changes depending on the biomarker concentration in buffer or spiked synthetic serum samples. The linear range was found as 0.1 ng/mL-100 ng/mL for AFP and 0.1-10 ng/mL for MUC16. Limit-of-detection (LOA) was calculated as 1.054 ng/mL and 0.413 ng/mL for AFP and MUC16, respectively. Interferent molecules, Her2, Immunoglobulin G (IgG) and bovine serum albumin (BSA) were tested on the system. Furthermore, synthetic serum samples spiked with selected analyte molecule were applied on the system and measured successfully.
机译:对于需要连续,实时监控特定疾病的表示未满足的需要科学。显然,癌症是最重要的疾病,其中关键的是要提高患者的生存率和监测疾病预后的比率之一。在此,一种新型的免疫测定用于检测癌症生物标志物的开发,使用甲胎蛋白(AFP)和粘蛋白16(MUC16)作为模型分析物。使用金粒子(AuNP)生物缀合物作为信号生产工具,在硝化纤维素(NC)膜制备相关抗体(Ab)缀合的金纳米粒子。为了构建一个点状的点的护理(POC)的免疫测定,半胱胺缀合的AuNP(的AuNP-CYS)被固定在NC膜和抗体缀合到该检测垫的纳米颗粒,在与包含该样本的处理AFP或MUC16这对肝脏和卵巢癌众所周知的蛋白质生物标志物。通过使用在金纳米粒子的比色性质的改变,肿瘤标记物的检测是通过在最后阶段使用智能手机图像和颜色分析软件来实现的。图像J应用被用于颜色的评价的变化取决于在缓冲器或合成的加标血清样品生物标志物的浓度。线性范围被发现为0.1毫微克/毫升,100纳克/毫升为AFP和0.1-10毫微克/毫升为MUC16。极限的检测(LOA)计算为1.054 ng / mL和用于分别AFP和MUC16,0.413纳克/毫升。干扰分子,HER2,免疫球蛋白G(IgG)和牛血清白蛋白(BSA)在系统上进行了测试。此外,与所选择的分析物分子掺入合成的血清样品施加在系统上,并成功地进行测定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号